NovaBridge Intangible Assets from 2010 to 2026
| NBP Stock | 3.29 0.07 2.17% |
Intangible Assets | First Reported 2010-12-31 | Previous Quarter 15 M | Current Value 14.2 M | Quarterly Volatility 56.4 M |
Check NovaBridge Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NovaBridge Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 M, Interest Expense of 87.1 K or Selling General Administrative of 432.4 M, as well as many indicators such as Price To Sales Ratio of 153, Dividend Yield of 8.0E-4 or PTB Ratio of 0.32. NovaBridge financial statements analysis is a perfect complement when working with NovaBridge Biosciences Valuation or Volatility modules.
NovaBridge | Intangible Assets | Build AI portfolio with NovaBridge Stock |
Evaluating NovaBridge Biosciences's Intangible Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into NovaBridge Biosciences's fundamental strength.
Latest NovaBridge Biosciences' Intangible Assets Growth Pattern
Below is the plot of the Intangible Assets of NovaBridge Biosciences over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. NovaBridge Biosciences' Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NovaBridge Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Intangible Assets | 10 Years Trend |
|
Intangible Assets |
| Timeline |
NovaBridge Intangible Assets Regression Statistics
| Arithmetic Mean | 112,353,157 | |
| Geometric Mean | 84,245,803 | |
| Coefficient Of Variation | 50.20 | |
| Mean Deviation | 45,511,406 | |
| Median | 148,844,000 | |
| Standard Deviation | 56,399,550 | |
| Sample Variance | 3180.9T | |
| Range | 134.6M | |
| R-Value | (0.82) | |
| Mean Square Error | 1117.3T | |
| R-Squared | 0.67 | |
| Significance | 0.000058 | |
| Slope | (9,146,770) | |
| Total Sum of Squares | 50894.5T |
NovaBridge Intangible Assets History
About NovaBridge Biosciences Financial Statements
NovaBridge Biosciences shareholders use historical fundamental indicators, such as Intangible Assets, to determine how well the company is positioned to perform in the future. Although NovaBridge Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in NovaBridge Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on NovaBridge Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Intangible Assets | 15 M | 14.2 M |
Pair Trading with NovaBridge Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NovaBridge Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NovaBridge Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with NovaBridge Stock
Moving against NovaBridge Stock
| 0.7 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.56 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.56 | DSGN | Design Therapeutics | PairCorr |
| 0.53 | SAB | Sonic Healthcare Earnings Call Tomorrow | PairCorr |
| 0.51 | PYC | Physiomics Plc | PairCorr |
The ability to find closely correlated positions to NovaBridge Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NovaBridge Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NovaBridge Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NovaBridge Biosciences to buy it.
The correlation of NovaBridge Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NovaBridge Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NovaBridge Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NovaBridge Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for NovaBridge Stock Analysis
When running NovaBridge Biosciences' price analysis, check to measure NovaBridge Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBridge Biosciences is operating at the current time. Most of NovaBridge Biosciences' value examination focuses on studying past and present price action to predict the probability of NovaBridge Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBridge Biosciences' price. Additionally, you may evaluate how the addition of NovaBridge Biosciences to your portfolios can decrease your overall portfolio volatility.